In Wave 2, remdesivir did not reach statistical significance in the unadjusted analysis [HR 0.91 (95% CI 0.73 to 1.14) p = 0.42] or in the imputed propensity model [HR 1.23 (95% CI 0.94 to 1.62) p = 0.13].
← all excerpts
Inpatient COVID-19 mortality has reduced over time: Results from an observational cohort.
1
0.4200
0.4200